The BREATH-TRACHER 2 Trial: Protocol for a Retrospective Mixed Methods Study to Establish the Utility of a Wearable Device in the Detection of Chronic Obstructive Pulmonary Disease Exacerbations
The BREATH-TRACHER 2 study will evaluate the use of the Frontier X2 device in participants with COPD in home settings. The Frontier X2 device, if successful, has the potential to transform COPD management and support proactive care, leading to enhanced clinical outcomes and reduced disease mortality and morbidity.
Authors
- Alexander B. Mullen (ORCID: https://orcid.org/0000-0001-7475-5543)
- Louise Hamilton (ORCID: https://orcid.org/0009-0000-3720-3547)
- Beyza Toprak (ORCID: https://orcid.org/0009-0002-8917-5415)
- Burcu Kolukisa Birgec (ORCID: https://orcid.org/0009-0009-7173-0864)
Institutions
- University of Strathclyde (GB)
- Glasgow Centre for Population Health (GB)
Publication Details
- Journal
- JMIR Research Protocols
- Published
- 2025-11-26
- DOI
- https://doi.org/10.2196/79503
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00